Share capital (Narrative) (Details)
|
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
|
|
|
Dec. 05, 2025
USD ($)
shares
|
Dec. 05, 2025
USD ($)
|
Jul. 14, 2025
USD ($)
$ / shares
shares
|
Jun. 02, 2025
USD ($)
$ / shares
shares
|
Mar. 10, 2025
USD ($)
$ / shares
shares
|
Feb. 10, 2025
USD ($)
$ / shares
shares
|
Nov. 14, 2024
USD ($)
$ / shares
shares
|
May 03, 2024
USD ($)
|
Oct. 28, 2024
shares
|
Jun. 28, 2024
USD ($)
$ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
shares
|
Dec. 29, 2025 |
Dec. 05, 2025
$ / shares
|
Dec. 05, 2025
$ / shares
|
Jul. 15, 2025
$ / shares
|
Oct. 27, 2024
shares
|
Jul. 30, 2024
$ / shares
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding common shares | shares |
|
|
|
|
|
|
|
|
10,846,721
|
|
25,176,303
|
11,816,721
|
|
|
|
|
21,693,560
|
|
| Reverse share split ratio |
|
|
|
|
|
|
|
|
1-for-2
|
|
|
|
|
|
|
|
|
|
| Cash paid for interest |
|
|
|
|
|
|
|
|
|
|
$ 221,663
|
$ 40,563
|
|
|
|
|
|
|
| Accrued interest converted into common shares |
|
|
|
|
|
|
|
|
|
|
0
|
38,462
|
|
|
|
|
|
|
| Issuance of common shares upon conversion of debt |
|
|
|
|
|
|
|
|
|
|
|
5,210,962
|
|
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
$ 15,000,000
|
|
|
|
|
9,790,015
|
5,470,000
|
|
|
|
|
|
|
| Value of common shares issued |
|
|
|
|
|
|
|
|
|
|
$ 3,688,981
|
|
|
|
|
|
|
|
| Number of options exercised | shares |
|
|
|
|
|
|
|
|
|
|
145,000
|
|
|
|
|
|
|
|
| Exercise price of options exercised | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 1.11
|
|
|
|
|
|
|
|
| Total proceeds from IPO |
|
|
|
|
|
|
|
|
|
|
$ 0
|
2,049,716
|
|
|
|
|
|
|
| Share issuance cost |
|
|
|
|
|
|
|
|
|
|
653,504
|
0
|
|
|
|
|
|
|
| Proceeds from warrants exercised |
|
|
|
|
|
|
|
|
|
|
$ 9,874,998
|
$ 0
|
|
|
|
|
|
|
| Convertible Promissory Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount of convertible promissory notes |
|
|
|
|
|
|
|
$ 5,172,500
|
|
|
|
|
|
|
|
|
|
|
| Interest rate of convertible promissory notes |
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
| Terms of conversion |
|
|
|
|
|
|
|
|
|
|
(i) a 20% discount to the initial public offering price and (ii) $4.00; or if there had been a change of control, at a conversion price of $4.00 per common share. On or after January 1, 2025, conversion would be at the option of the holder at a conversion price of $4.00 per common share. The Company had the option to redeem all or any portion of the convertible notes at a price equal to 100% of the outstanding principal plus accrued and unpaid interest up to but not including the date of redemption. In the event of a change of control, the Company would offer to repurchase the convertible notes at a price equal to 101% of the principal plus accrued and unpaid interest up to but not including the date of repurchase.
|
|
|
|
|
|
|
|
| Conversion price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4
|
| Cash paid for interest |
|
|
|
|
|
|
|
|
|
$ 40,563
|
|
|
|
|
|
|
|
|
| Accrued interest converted into common shares |
|
|
|
|
|
|
|
|
|
38,462
|
|
|
|
|
|
|
|
|
| Issuance of common shares upon conversion of debt |
|
|
|
|
|
|
|
|
|
$ 5,172,500
|
|
|
|
|
|
|
|
|
| Issuance of common shares upon conversion of debt (Shares) | shares |
|
|
|
|
|
|
|
|
|
1,308,798
|
|
|
|
|
|
|
|
|
| Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common shares issued in connection with a private placement | shares |
|
|
|
|
|
|
|
|
|
1,461,250
|
|
|
|
|
|
|
|
|
| Value of common shares issued in connection with a private placement |
|
|
|
|
|
|
|
|
|
$ 5,845,000
|
|
|
|
|
|
|
|
|
| Common shares, price per share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4
|
|
|
|
|
|
|
|
|
| Share issuance cost |
|
|
|
|
|
|
|
|
|
$ 375,000
|
|
|
|
|
|
|
|
|
| Initial Public Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of units issued | shares |
|
|
|
|
|
|
970,000
|
|
|
|
|
|
|
|
|
|
|
|
| Price per share in IPO | $ / shares |
|
|
|
|
|
|
$ 4.125
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options exercised | shares |
|
|
|
|
|
|
145,500
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of options exercised | $ / shares |
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
|
| Total proceeds from IPO |
|
|
|
|
|
|
$ 4,002,705
|
|
|
|
|
|
|
|
|
|
|
|
| Share issuance cost |
|
|
|
|
|
|
$ 2,218,014
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value per share | $ / shares |
|
|
|
|
|
|
$ 2.65
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value per warrant | $ / shares |
|
|
|
|
|
|
$ 1.7419
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised | shares |
|
|
|
|
|
|
|
|
|
|
129,905
|
|
|
|
|
|
|
|
| Proceeds from warrants exercised |
|
|
|
|
|
|
|
|
|
|
$ 602,756
|
|
|
|
|
|
|
|
| Regulation A Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from offering |
|
|
|
|
$ 4,172,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of units issued | shares |
|
|
|
|
1,490,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common shares, price per share | $ / shares |
|
|
|
|
$ 2.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants granted | $ / shares |
|
|
|
|
$ 2.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issuance cost |
|
|
|
|
$ 483,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value per share | $ / shares |
|
|
|
|
$ 3.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value per warrant | $ / shares |
|
|
|
|
$ 2.63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised | shares |
|
|
1,340,000
|
|
|
|
|
|
|
|
1,473,800
|
|
|
|
|
|
|
|
| Proceeds from warrants exercised |
|
|
$ 3,752,000
|
|
|
|
|
|
|
|
$ 4,126,639
|
|
|
|
|
|
|
|
| Warrants outstanding granted during the period | shares |
|
|
|
|
|
|
|
|
|
|
1,490,000
|
|
|
|
|
|
|
|
| Regulation A Offering [Member] | Series A Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding granted during the period | shares |
|
|
|
|
|
|
|
|
|
|
1,340,000
|
|
|
|
|
|
|
|
| Regulation A Offering [Member] | Series B Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding granted during the period | shares |
|
|
|
|
|
|
|
|
|
|
1,340,000
|
|
|
|
|
|
|
|
| Regulation A Offering [Member] | Series A and B Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants granted | $ / shares |
|
|
$ 3.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of warrants granted |
|
|
$ 4,954,518
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised | shares |
2,680,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from warrants exercised |
$ 5,145,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.92
|
|
$ 3.75
|
|
|
| Regulation A Offering [Member] | Series C and D Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
5 years 6 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Incremental fair value of warrants granted |
|
$ 884,331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of warrants granted |
|
$ 5,998,449
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2
|
|
|
|
| Warrants outstanding granted during the period | shares |
4,020,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| June 2025 Public Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from offering |
|
|
|
$ 7,006,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of units issued | shares |
|
|
|
2,260,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common shares, price per share | $ / shares |
|
|
|
$ 3.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants granted | $ / shares |
|
|
|
$ 3.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issuance cost |
|
|
|
$ 809,606
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value per share | $ / shares |
|
|
|
$ 2.63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value per warrant | $ / shares |
|
|
|
$ 1.92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Standby Equity Purchase Agreement (the "SEPA") [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
$ 15,000,000
|
|
|
|
|
$ 8,427,416
|
|
|
|
|
|
|
|
| Share price as percentage of market price |
|
|
|
|
|
97.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common shares issued | shares |
|
|
|
|
|
105,840
|
|
|
|
|
3,677,853
|
|
|
|
|
|
|
|
| Value of common shares issued |
|
|
|
|
|
|
|
|
|
|
$ 8,706,270
|
|
|
|
|
|
|
|
| Proceeds from share issuance used to repay outstanding debentures |
|
|
|
|
|
|
|
|
|
|
$ 4,430,833
|
|
|
|
|
|
|
|
| Common shares, price per share | $ / shares |
|
|
|
|
|
$ 2.83
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment of structuring fee |
|
|
|
|
|
$ 25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal fees |
|
|
|
|
|
$ 391,898
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATM Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital Note Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity distribution agreement commission rate |
|
|
|
|
|
|
|
|
|
|
|
|
3.00%
|
|
|
|
|
|